8-K: Five9 Appoints Maria Walker to Board of Directors, Enhancing Financial Expertise

Five9, Inc. has appointed Maria Walker, a seasoned financial executive, to its Board of Directors, effective May 21, 2024.

Summary

• Five9, Inc. has appointed Maria Walker to its Board of Directors as a Class I Director, with her term expiring at the 2027 annual meeting of stockholders.
• Ms. Walker will also serve on the Audit Committee of the Board.
• She brings extensive experience from her roles as Founding Partner and CFO of Patient Square Capital, CFO of Montes Archimedes Acquisition Corp, and CEO of Recuerdo Therapeutics, Inc.
• Ms. Walker also held leadership positions at KPMG U.S., including Audit Partner and Global Lead Partner of Private Equity.
• She previously served on the board of directors of Forgerock, Inc. until its sale in 2023.
• Ms. Walker will receive an initial equity grant of restricted stock units (RSUs) valued at $400,000, vesting over three years, and an additional RSU grant valued at $200,000, vesting in one year.
• She will not be eligible for the regular 2025 automatic annual grant of RSUs to non-employee directors but will be eligible for future grants.
• Five9 has entered into an indemnification agreement with Ms. Walker, protecting her against liabilities arising from her service to the company.

Sentiment

Score: 7

Explanation: The document reflects a positive development with the appointment of a qualified board member, but it is a routine corporate action and not a major event.

Positives

• The appointment of Maria Walker brings significant financial expertise to the Five9 Board of Directors.
• Her experience as a CFO and in private equity will likely benefit the company's financial oversight and strategic direction.
• The indemnification agreement provides a level of security for Ms. Walker in her role as a director.

Risks

• There are no immediate risks identified in the document.
• The document does not mention any potential negative impacts of this appointment.

Future Outlook

Ms. Walker will be eligible for regular automatic grants of RSUs after 2025, assuming her continued service on the Board.

Industry Context

The appointment of a seasoned financial executive like Maria Walker is a common practice for publicly traded companies to enhance their board's expertise and oversight capabilities, particularly in the technology sector.

Comparison to Industry Standards

• The appointment of a CFO or former CFO to a board is a common practice in the technology industry, similar to companies like Salesforce or Workday who have board members with strong financial backgrounds.
• The compensation package for non-employee directors, including equity grants, is consistent with industry standards for companies of Five9's size and market capitalization.
• Indemnification agreements are standard practice for board members to protect them from potential liabilities, similar to what is offered by other public companies.

Management Changes

Stakeholder Impact

• Shareholders may view the appointment of a seasoned financial executive positively, potentially increasing confidence in the company's governance.
• Employees may see this as a positive step for the company's future.

Next Steps

• Ms. Walker will begin her service on the Board and the Audit Committee.
• The RSU grants will be issued to Ms. Walker.

Key Dates

Keywords

Board of Directors, Maria Walker, Audit Committee, Director Appointment, Financial Expertise, Indemnification Agreement, Restricted Stock Units, Corporate Governance